CIK: 0001381843 · Show all filings
Period: Q4 2015 (← Previous) (Next →)
Filing Date: Jan 11, 2016
Total Value ($000): $212,476 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | LIFEPOINT HEALTH INC | 373,430 | $27,410 | 12.9% | $67.19 | — | COM | 53219L109 |
| — | GNC HLDGS INC | 821,190 | $25,473 | 12.0% | $31.02 | — | COM CL A | 36191G107 |
| GILD | GILEAD SCIENCES INC | 229,300 | $23,203 | 10.9% | $67.47 | +8.0% | COM | 375558103 |
| — | AMAG PHARMACEUTICALS INC | 520,000 | $15,699 | 7.4% | $30.19 | — | COM | 00163U106 |
| — | MAGELLAN HEALTH INC | 248,934 | $15,349 | 7.2% | $63.62 | — | COM NEW | 559079207 |
| — | VARIAN MED SYS INC | 184,000 | $14,867 | 7.0% | $73.78 | — | COM | 92220P105 |
| ELV | ANTHEM INC | 105,700 | $14,739 | 6.9% | $119.87 | -0.2% | COM | 036752103 |
| CRL | CHARLES RIV LABS INTL INC | 182,707 | $14,688 | 6.9% | $63.72 | +13.2% | COM | 159864107 |
| — | TRIPLE-S MGMT CORP | 606,944 | $14,512 | 6.8% | $19.58 | — | CL B | 896749108 |
| ANIK | ANIKA THERAPEUTICS INC | 378,745 | $14,453 | 6.8% | $37.89 | +1.0% | COM | 035255108 |
| — | FEI CO | 178,763 | $14,263 | 6.7% | $79.79 | — | COM | 30241L109 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 1,051,277 | $14,129 | 6.6% | $17.80 | -13.1% | COM | 868459108 |
| — | SYMMETRY SURGICAL INC | 298,427 | $2,746 | 1.3% | $8.60 | — | COM | 87159G100 |
| ICCC | IMMUCELL CORP | 125,292 | $945 | 0.4% | $4.82 | +46.8% | COM PAR $0.10 | 452525306 |